CHARLES SCHWAB INVESTMENT MANAGEMENT INC
Position in LXRX — Lexicon Pharmaceuticals, Inc.
CIK 884546
SAN FRANCISCO, CA
Position in LXRX
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$4,696,260
+$2,650,636 QoQ
Shares Held
1,956,775
+49.2% QoQ
Ownership
0.440%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#12
of 148 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in LXRX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026CHARLES SCHWAB INVESTMENT MANAGEMENT INC holds $7,346,663,053 across 299 Biotechnology names. LXRX ranks #144 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
2,041,282 | $1,013,966,007 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
846,306 | $527,705,642 | |
| 3 | RVMD |
Revolution Medicines, Inc.
|
1,917,025 | $359,020,441 | |
| 4 | MRNA |
Moderna, Inc.
|
4,838,884 | $338,867,045 | |
| 5 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
755,377 | $227,391,137 | |
| 6 | INCY |
Incyte Corp
|
1,692,439 | $191,854,884 | |
| 7 | RPRX |
Royalty Pharma plc
|
3,083,528 | $172,893,414 | |
| 8 | CYTK |
Cytokinetics Inc
|
1,565,781 | $133,388,883 |
All Filings in LXRX
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $4,696,260 | 1,956,775 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $2,045,624 | 1,311,298 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $1,213,391 | 1,055,123 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $1,545,253 | 1,144,632 | Shares | Sole | 2025-11-10 | |
| 2025-06-30 | $839,065 | 883,227 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $529,354 | 1,150,771 | Shares | Sole | 2025-09-15 | |
| 2024-12-31 | $881,407 | 1,191,091 | Shares | Sole | 2025-02-06 | |
| 2024-09-30 | $2,225,153 | 1,417,295 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $2,283,368 | 1,359,148 | Shares | Sole | 2024-08-12 | |
| 2024-03-31 | $2,114,695 | 881,123 | Shares | Sole | 2024-05-09 | |
| 2023-12-31 | $1,322,187 | 864,175 | Shares | Sole | 2024-02-06 | |
| 2023-09-30 | $928,593 | 851,921 | Shares | Sole | 2023-11-08 | |
| 2023-06-30 | $1,631,338 | 712,375 | Shares | Sole | 2023-08-10 | |
| 2023-03-31 | $1,673,324 | 688,611 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $1,329,245 | 695,940 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $1,589,947 | 662,478 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $808,289 | 434,564 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $1,047,357 | 501,128 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $1,924,366 | 488,418 | Shares | Sole | 2022-02-11 | |
| 2021-09-30 | $2,288,569 | 475,794 | Shares | Sole | 2021-11-16 | |
| 2021-06-30 | $2,155,941 | 469,704 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $2,484,336 | 423,226 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 | $1,141,548 | 333,786 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $424,985 | 295,129 | Shares | Sole | 2020-11-13 | |
| 2020-06-30 | $567,788 | 283,894 | Shares | Sole | 2020-08-20 | |
| 2020-03-31 | $520,051 | 266,693 | Shares | Sole | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||